Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata

• Status: Completed
• Trial end date: 2021-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The goal of this study is to evaluate the efficacy and safety of combined CO2 fractional laser with Bimatoprost 0.03% as novel treatment of alopecia areata.

The main question to study is will the bimatoprost facilitate hair growth if added to fractional CO2 laser treatment in Alopecia areata.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ahmed Hassan Nouh MD
• Treatments: Bimatoprost

Criteria

Inclusion Criteria:

• Patients with alopecia areata of the scalp (multilocuolaris or single patch).

• Patient aged from 16- 55 years old in both sex.

• Other treatment wash out period is two months.

Exclusion Criteria:

• Ophiasis pattern and other patterns of alopecia areata.

• Chronic diseases of liver, heart, kidney and blood

• Pregnant women

• Infections of skin in site of intervention